DrugDashboards

Rynex DM

Brompheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride · PHENYLEPHRINE HYDROCHLORIDE 2.5 mg/5mL; BROMPHENIRAMINE MALEATE 1 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 5 mg/5mL · Liquid · Oral · Edwards Pharmaceuticals, Inc

NDC 00485-0204-16 · 473 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is up 18% over the past year, to $0.0514 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.02$0.04$0.06Nov 2013Sep 2026$0.0514
104 price points · per MLSource: CMS NADAC

Medicaid spend (2025)

$678,420
41,208 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for dextromethorphan hydrobromide, brompheniramine maleate, phenylephrine hydrochloride (other) in the next 90 days

sole-source market · price up 8% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M012
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Brompheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride (Liquid)

LabelerStrengthFirst seenLast seen
Alternative Pharmacal CorporationDEXTROMETHORPHAN HYDROBROMIDE 20 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5mL; BROMPHENIRAMINE MALEATE 4 mg/5mLAug 26, 2026Sep 2, 2026
Edwards Pharmaceuticals, IncPHENYLEPHRINE HYDROCHLORIDE 2.5 mg/5mL; BROMPHENIRAMINE MALEATE 1 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 5 mg/5mLAug 26, 2026Sep 2, 2026
Alternative Pharmacal CorporationDEXTROMETHORPHAN HYDROBROMIDE 4 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 20 mg/5mL; BROMPHENIRAMINE MALEATE 10 mg/5mLJul 22, 2026Aug 19, 2026
Edwards Pharmaceuticals, IncPHENYLEPHRINE HYDROCHLORIDE 1 mg/5mL; BROMPHENIRAMINE MALEATE 5 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 2.5 mg/5mLJul 22, 2026Aug 19, 2026
Alternative Pharmacal CorporationBROMPHENIRAMINE MALEATE 4 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5mLJul 15, 2026Jul 15, 2026
Edwards Pharmaceuticals, IncBROMPHENIRAMINE MALEATE 1 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 5 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 2.5 mg/5mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Rynex DM — NDC 00485-0204-16," retrieved September 3, 2026, https://drugdashboards.com/drug/00485020416.

Free to cite with attribution — see how the data is put together.